• Clinical trials of hydroxychloroquine are stopped temporarily

    | 27 May 2020 |

    Five clinical trials in Denmark testing the efficacy of hydroxychloroquine on COVID-19 are discontinued until further notice. This takes place after a major international study has indicated that there is no beneficial effect of using the product; in contrast, there could be serious adverse reactions.

  • Several actions taken to ensure the supply of medicine during COVID-19

    | 27 May 2020 |

    Several actions have been taken nationally to counter supply problems affecting vital medicines during the COVID-19 pandemic. Work is also done at the EU level to ensure the supply of medicines.

  • The Danish Medicines Agency will be closed on 22 May 2020

    | 18 May 2020 |

    The Danish Medicines Agency will be closed on 22 May 2020, the day after Ascension Day. However, we process urgent applications for compassionate use permits (applications for dispensing of non-marketed medicines manufactured by pharmaceutical companies).

  • Compassionate use permit for Remdesivir

    | 05 May 2020 |

    The Danish Medicines Agency would like to inform you that it is possible to apply for a general compassionate use permit for Remdesivir for the treatment of COVID-19 patients who cannot be included in one of the protocol-based clinical trials that are currently being conducted in Denmark.